Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Malignant Head and Neck Neoplasm”

179 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 179 results

Testing effectiveness (Phase 2)Study completedNCT01173172
What this trial is testing

Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Taipei Veterans General Hospital, Taiwan 17
Testing effectiveness (Phase 2)Study completedNCT00713219
What this trial is testing

Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 14
Not applicableUnknownNCT00415298
What this trial is testing

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of California, San Diego 12
Early research (Phase 1)Study completedNCT00470496
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Testing effectiveness (Phase 2)Ended earlyNCT03937141
What this trial is testing

Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer

Who this might be right for
Metastatic Head and Neck CancerRecurrent Head and Neck Cancer
Chinook Therapeutics, Inc. (formerly Aduro) 16
Not applicableEnded earlyNCT03402737
What this trial is testing

SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N

Who this might be right for
Head and Neck Neoplasm
University Hospital, Ghent 6
Testing effectiveness (Phase 2)Looking for participantsNCT06869473
What this trial is testing

Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Recurrent Head and Neck CancerMetastatic Head and Neck Cancer
Gruppo Oncologico del Nord-Ovest 67
Testing effectiveness (Phase 2)Study completedNCT01264328
What this trial is testing

Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 40
Testing effectiveness (Phase 2)Ended earlyNCT00101075
What this trial is testing

Title XELOX FOR SALIVARY GLAND CANCERS

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 9
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Study completedNCT02358031
What this trial is testing

Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)

Who this might be right for
Recurrent Head and Neck CancerMetastatic Head and Neck Cancer
Merck Sharp & Dohme LLC 882
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00454779
What this trial is testing

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

Who this might be right for
Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
Amgen 113
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT01172470
What this trial is testing

Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients

Who this might be right for
Head and Neck Cancer
University of Chicago 34
Testing effectiveness (Phase 2)Study completedNCT00148122
What this trial is testing

A New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Michigan Rogel Cancer Center 40
Not applicableWithdrawnNCT05850663
What this trial is testing

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck CancerGynecologic CancerCervical Cancer+1 more
University of Oklahoma
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Looking for participantsNCT07501650
What this trial is testing

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Small Cell CarcinomaMetastatic Head and Neck Cancer+1 more
Thomas Jefferson University 6
Load More Results